2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Guidance covers diagnosis, risk assessment and outcomes, pharmacological & invasive treatments, MI with non-obstructive coronary arteries and alternative diagnoses, special populations, long-term management, quality measures, management strategy, key messages and gaps in evidence

SPS commentary:

Questions and answers on antithrombotic therapy and revascularisation strategies and on workup diagnosis and risk stratification are provided as companion documents to the guidelines.


European Heart Journal

Resource links:

Q+A’s on antithrombotic therapy

Q+A’s on workup diagnosis and risk stratification